TD Waterhouse Canada’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

TD Waterhouse Canada’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-112	Closed	-$550	–	2095
2024 Q3	$550	Hold	112	–	–	﹤0.01%	1743
2024 Q2	$694	Hold	112	–	–	﹤0.01%	1756
2024 Q1	$830	Hold	112	–	–	﹤0.01%	1741
2023 Q4	$1.58K	Buy	+112	New	+$1.81K	﹤0.01%	1521

TD Waterhouse Canada's BIOR Position: Q4 2024 in Review

TD Waterhouse Canada sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2024, closing a stake of 112 shares — an estimated $550 sold.

TD Waterhouse Canada first reported a position in BIOR in Q4 2023 and held it in 4 quarters. The position peaked at $1.58K in Q4 2023. 0 funds tracked by Wall St. Rank hold BIOR as of Q4 2024.

TD Waterhouse Canada reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
TD Waterhouse Canada sold 112 Biora Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $550.
TD Waterhouse Canada first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2023 and held it in 4 quarters.
TD Waterhouse Canada's Biora Therapeutics, Inc. Common Stock position peaked at $1.58K in Q4 2023.
0 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2024.

Based on TD Waterhouse Canada's 13F filing for Q4 2024, filed 13 Feb 2025.